[Dopamine agonist in the treatment of Parkinson's disease]. / Agonisci dopaminy w leczeniu choroby Parkinsona.
Neurol Neurochir Pol
; 31(3): 545-54, 1997.
Article
em Pl
| MEDLINE
| ID: mdl-9446045
ABSTRACT
In the review paper is discussed the group of dopamine agonists which act directly on the postsynaptic receptors in the striatum, and have been used since over 20 years in the treatment of various stages of Parkinson's disease. For practical reasons they are divided in the paper into three groups drugs used formerly and now gradually withdrawn mainly because of various adverse effects, new drugs whose effectiveness and usefulness have not yet been confirmed clinically, and three drugs (bromocriptine, lisuride, pergolide) used fairly widely with clinically confirmed effectiveness. The mechanism of their action and clinical results are described.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doença de Parkinson
/
Bromocriptina
/
Lisurida
/
Pergolida
/
Agonistas de Dopamina
Limite:
Humans
Idioma:
Pl
Revista:
Neurol Neurochir Pol
Ano de publicação:
1997
Tipo de documento:
Article